MARKET INTRODUCTION
Kidney Fibrosis is a condition in which there is accumulation of excess amount of extracellular matrix which means the failed or abnormal tissue healing of kidney. Kidney fibrosis if not treated then it lead to chronic kidney disease and end stage kidney disease. Various drug categories are available such as, angiotensin II receptor blockers, ACE inhibitors etc. to treat kidney fibrosis.
MARKET DYNAMICS
The key market drivers for Kidney Fibrosis Treatment Market Includes, rising incidences of chronic diseases as well as renal disorders. Additionally increase prevalence of kidney fibrosis globally is also expected to fuel market growth. Moreover, rising R&D investments by pharmaceutical companies to develop novel treatment options to treat kidney fibrosis is also expected to drive market growth. Whereas, stringent regulatory approvals for drug and therapies is expected to hinder market growth during the forecast period.
MARKET SCOPE
The "Kidney Fibrosis Treatment Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Kidney Fibrosis Treatment market with detailed market segmentation by therapeutics and location of therapeutics. The Kidney Fibrosis Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Kidney Fibrosis Treatment Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Kidney Fibrosis Treatment Market is segmented on the basis of therapeutics and location of therapeutics. On basis of therapeutics the market is bifurcated as, angiotensin II receptor blockers, ACE inhibitors, Vasopeptidase inhibitors. And on the basis of location of therapeutics the market is segmented as, hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Kidney Fibrosis Treatment Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Kidney Fibrosis Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Kidney Fibrosis Treatment Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Kidney Fibrosis Treatment Market in these regions.
MARKET PLAYERS
The report covers key developments in the Kidney Fibrosis Treatment Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Kidney Fibrosis Treatment Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Kidney Fibrosis Treatment market in the global market. Below mentioned is the list of few companies engaged in the Kidney Fibrosis Treatment Market.
The report also includes the profiles of key players in Kidney Fibrosis Treatment Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Merck and Co.
- F. Hoffmann-La Roche Ltd
- Pfizer Inc
- Galectin Therapeutics
- La Jolla Pharmaceutical Company
- InterMune Inc
- ProMetric Life-Sciences, Inc
- Genzyme Corporation
- BioLine Rx
- Teva Pharmaceuticals
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Kidney Fibrosis Treatment Market - By Therapeutics
1.3.2 Kidney Fibrosis Treatment Market - By Location Of Therapeutics
1.3.3 Kidney Fibrosis Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. KIDNEY FIBROSIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. KIDNEY FIBROSIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. KIDNEY FIBROSIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. KIDNEY FIBROSIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. KIDNEY FIBROSIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. KIDNEY FIBROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS)
7.3.1. Overview
7.3.2. Angiotensin II receptor blockers (ARBs) Market Forecast and Analysis
7.4. ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS
7.4.1. Overview
7.4.2. Angiotensin Converting Enzyme (ACE) inhibitors Market Forecast and Analysis
7.5. PIRFENIDONE RENIN INHIBITORS
7.5.1. Overview
7.5.2. Pirfenidone Renin Inhibitors Market Forecast and Analysis
7.6. VASOPEPTIDASE INHIBITORS
7.6.1. Overview
7.6.2. Vasopeptidase Inhibitors Market Forecast and Analysis
8. KIDNEY FIBROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - LOCATION OF THERAPEUTICS
8.1. OVERVIEW
8.2. LOCATION OF THERAPEUTICS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. KIDNEY FIBROSIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Kidney Fibrosis Treatment Market Overview
9.1.2 North America Kidney Fibrosis Treatment Market Forecasts and Analysis
9.1.3 North America Kidney Fibrosis Treatment Market Forecasts and Analysis - By Therapeutics
9.1.4 North America Kidney Fibrosis Treatment Market Forecasts and Analysis - By Location Of Therapeutics
9.1.5 North America Kidney Fibrosis Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Kidney Fibrosis Treatment Market
9.1.5.1.1 United States Kidney Fibrosis Treatment Market by Therapeutics
9.1.5.1.2 United States Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.1.5.2 Canada Kidney Fibrosis Treatment Market
9.1.5.2.1 Canada Kidney Fibrosis Treatment Market by Therapeutics
9.1.5.2.2 Canada Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.1.5.3 Mexico Kidney Fibrosis Treatment Market
9.1.5.3.1 Mexico Kidney Fibrosis Treatment Market by Therapeutics
9.1.5.3.2 Mexico Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.2. EUROPE
9.2.1 Europe Kidney Fibrosis Treatment Market Overview
9.2.2 Europe Kidney Fibrosis Treatment Market Forecasts and Analysis
9.2.3 Europe Kidney Fibrosis Treatment Market Forecasts and Analysis - By Therapeutics
9.2.4 Europe Kidney Fibrosis Treatment Market Forecasts and Analysis - By Location Of Therapeutics
9.2.5 Europe Kidney Fibrosis Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Kidney Fibrosis Treatment Market
9.2.5.1.1 Germany Kidney Fibrosis Treatment Market by Therapeutics
9.2.5.1.2 Germany Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.2.5.2 France Kidney Fibrosis Treatment Market
9.2.5.2.1 France Kidney Fibrosis Treatment Market by Therapeutics
9.2.5.2.2 France Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.2.5.3 Italy Kidney Fibrosis Treatment Market
9.2.5.3.1 Italy Kidney Fibrosis Treatment Market by Therapeutics
9.2.5.3.2 Italy Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.2.5.4 Spain Kidney Fibrosis Treatment Market
9.2.5.4.1 Spain Kidney Fibrosis Treatment Market by Therapeutics
9.2.5.4.2 Spain Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.2.5.5 United Kingdom Kidney Fibrosis Treatment Market
9.2.5.5.1 United Kingdom Kidney Fibrosis Treatment Market by Therapeutics
9.2.5.5.2 United Kingdom Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.2.5.6 Rest of Europe Kidney Fibrosis Treatment Market
9.2.5.6.1 Rest of Europe Kidney Fibrosis Treatment Market by Therapeutics
9.2.5.6.2 Rest of Europe Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Kidney Fibrosis Treatment Market Overview
9.3.2 Asia-Pacific Kidney Fibrosis Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Kidney Fibrosis Treatment Market Forecasts and Analysis - By Therapeutics
9.3.4 Asia-Pacific Kidney Fibrosis Treatment Market Forecasts and Analysis - By Location Of Therapeutics
9.3.5 Asia-Pacific Kidney Fibrosis Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Kidney Fibrosis Treatment Market
9.3.5.1.1 Australia Kidney Fibrosis Treatment Market by Therapeutics
9.3.5.1.2 Australia Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.3.5.2 China Kidney Fibrosis Treatment Market
9.3.5.2.1 China Kidney Fibrosis Treatment Market by Therapeutics
9.3.5.2.2 China Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.3.5.3 India Kidney Fibrosis Treatment Market
9.3.5.3.1 India Kidney Fibrosis Treatment Market by Therapeutics
9.3.5.3.2 India Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.3.5.4 Japan Kidney Fibrosis Treatment Market
9.3.5.4.1 Japan Kidney Fibrosis Treatment Market by Therapeutics
9.3.5.4.2 Japan Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.3.5.5 South Korea Kidney Fibrosis Treatment Market
9.3.5.5.1 South Korea Kidney Fibrosis Treatment Market by Therapeutics
9.3.5.5.2 South Korea Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.3.5.6 Rest of Asia-Pacific Kidney Fibrosis Treatment Market
9.3.5.6.1 Rest of Asia-Pacific Kidney Fibrosis Treatment Market by Therapeutics
9.3.5.6.2 Rest of Asia-Pacific Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Kidney Fibrosis Treatment Market Overview
9.4.2 Middle East and Africa Kidney Fibrosis Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Kidney Fibrosis Treatment Market Forecasts and Analysis - By Therapeutics
9.4.4 Middle East and Africa Kidney Fibrosis Treatment Market Forecasts and Analysis - By Location Of Therapeutics
9.4.5 Middle East and Africa Kidney Fibrosis Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Kidney Fibrosis Treatment Market
9.4.5.1.1 South Africa Kidney Fibrosis Treatment Market by Therapeutics
9.4.5.1.2 South Africa Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.4.5.2 Saudi Arabia Kidney Fibrosis Treatment Market
9.4.5.2.1 Saudi Arabia Kidney Fibrosis Treatment Market by Therapeutics
9.4.5.2.2 Saudi Arabia Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.4.5.3 U.A.E Kidney Fibrosis Treatment Market
9.4.5.3.1 U.A.E Kidney Fibrosis Treatment Market by Therapeutics
9.4.5.3.2 U.A.E Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.4.5.4 Rest of Middle East and Africa Kidney Fibrosis Treatment Market
9.4.5.4.1 Rest of Middle East and Africa Kidney Fibrosis Treatment Market by Therapeutics
9.4.5.4.2 Rest of Middle East and Africa Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Kidney Fibrosis Treatment Market Overview
9.5.2 South and Central America Kidney Fibrosis Treatment Market Forecasts and Analysis
9.5.3 South and Central America Kidney Fibrosis Treatment Market Forecasts and Analysis - By Therapeutics
9.5.4 South and Central America Kidney Fibrosis Treatment Market Forecasts and Analysis - By Location Of Therapeutics
9.5.5 South and Central America Kidney Fibrosis Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Kidney Fibrosis Treatment Market
9.5.5.1.1 Brazil Kidney Fibrosis Treatment Market by Therapeutics
9.5.5.1.2 Brazil Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.5.5.2 Argentina Kidney Fibrosis Treatment Market
9.5.5.2.1 Argentina Kidney Fibrosis Treatment Market by Therapeutics
9.5.5.2.2 Argentina Kidney Fibrosis Treatment Market by Location Of Therapeutics
9.5.5.3 Rest of South and Central America Kidney Fibrosis Treatment Market
9.5.5.3.1 Rest of South and Central America Kidney Fibrosis Treatment Market by Therapeutics
9.5.5.3.2 Rest of South and Central America Kidney Fibrosis Treatment Market by Location Of Therapeutics
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. KIDNEY FIBROSIS TREATMENT MARKET, KEY COMPANY PROFILES
11.1. MERCK AND CO.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. F. HOFFMAN-LA ROCHE LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GALECTIN THERAPEUTICS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LA JOLLA PHARMACEUTICAL COMPANY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. INTERMUNE INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PROMETIC LIFE-SCIENCES INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GENZYME CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BIOLINE RX
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1.Merck and Co.
2.F. Hoffman-La Roche Ltd
3.Pfizer Inc
4.Galectin Therapeutics
5.La Jolla Pharmaceutical Company
6.InterMune Inc
7.ProMetic Life-Sciences Inc
8.Genzyme Corporation
9.BioLine Rx
10.Teva Pharmaceuticals
Global Cryolipolysis Machine Market Grow..
According to this latest study, the 2020 growth of Cryolipol..
+1-646-791 7070US (Toll Free)